Report Categories
View AllRecent Articles
View All
The quiet strength in Arcutis ARQT business model Investors Pile In 20260508
Tenax Therapeutics TENX Stock Movers Q4 2025 EPS Tops Views
CXAIW CXApp Warr warrants draw investor attention as company navigates AI transformation amid market uncertainty
ColgatePalmolive Stock Shows Potential as Defensive Play Gains Traction in Broadening Market
Manhattan Associates MANH Delivers Q1 2026 Beat EPS 124 vs 114 Expected
Chevron CVX Q1 2026 Earnings 141 EPS Surges Past 096 Estimates
Elbit Systems Shares Dip 132 as Defense Stock Tests Key Support Levels
Market Analysis Investors Business Daily Provides InDepth Stock Market Review Amid Mixed Signals
CFR Q1 2026 Earnings EPS Beats Estimates as Strong Net Interest Income Offsets Broader Bank Pressures
Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project
BKSY BlackSky Technology Inc posts far narrower Q4 2025 loss than expected but shares drop 367 percent
Keros Therapeutics KROS Business Update Q4 2025 Earnings Underperform
What risks should investors watch for Newmont NEM stock 272 20260418
Xperi XPER Stock Analysis Buy or Sell Q4 2025 EPS Beats Forecasts
Yimutian YMT Company Health Yimutian Inc ADS posts net loss with no analyst estimates
Service SCI Stock Growth Opportunities 185 20260415
McKesson Corporation MCK Stock Treasury Trade 045 20260416
CLRO ClearOne Inc DE shares rise 331 percent after narrower than expected Q1 2018 loss beats consensus estimates
WSBCO WesBanco Inc Series B Preferred Depositary Shares posts Q4 2025 EPS miss rises 016 percent as investors take results in stride
External Links
Soybean Futures Gain Ground in Thursday Trading Session
Prudential plc Acquires 75 Stake in Bharti Life Insurance to Expand India Presence
Sensex Nifty Show Mixed Trends Hind Zinc SBI Force Motors Among Most Active Stocks
Arvind Sanger Cautiously Optimistic on Indian Markets Eyes Earnings Revival
FTSE 100 Edges Higher as Traders Assess Iran Nuclear Deal Uncertainty
Novartis Raises FullYear Guidance on Sales and Profit
Mesa Laboratories Stock Plunges Amid Heavy Selling Pressure